FOS and Uterine leiomyoma: Taken together, these results suggest an important role played by AP-1 in uterine muscle cell enhancer regulation, the perturbation of which results in significant changes in enhancer regulation and gene expression, including the dysregulation of ECM-associated genes, a hallmark of uterine leiomyoma disease pathogenesis.